FDA Approves Expanded Indication for Max 3™ Syringeless MR Injector from Bracco

FDA Approval of VUEWAY® (gadopiclenol) injection Imaging Bulk Package (IBP) Enhances Options for Efficient, Sustainable MRI Contrast Delivery Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leader in diagnostic imaging, announced today that the U.S. Food and Drug Administration (FDA) has expanded the indication for the Bracco-branded Max 3™, a Rapid […]

Preferred Office Network Celebrates 15 Years of Connections, Community, and Growth

One of the world's largest flexible workspace networks marks a milestone anniversary this year. Preferred Office Network, a leading global network of independently owned flexible workspace providers, is proud to celebrate its 15-year anniversary this year. Since its founding in 2010, Preferred has become a trusted partner for connecting some of the world's largest companies

GV20 Therapeutics Announces Achievement of Milestone under Antibody-Drug Conjugate Collaboration with Mitsubishi Tanabe Pharma Corporation

GV20 Therapeutics (GV20), a clinical-stage AI-poweredbiotherapeutics company, announced that it has received a milestone payment under its collaboration agreement with Mitsubishi Tanabe Pharma Corporation (MTPC). GV20 and MTPC entered into this collaboration in early 2025 to leverage GV20's antibodies, which are specifically directed against novel tumor antigen targets discovered through GV20's proprietary STEAD AI platform,

TEMPLE UNIVERSITY LAUNCHES CUSTOM DONOR-ADVISED FUND PROGRAM IN PARTNERSHIP WITH FOUNDATION SOURCE AND CHARITYVEST

Partnership provides Temple alumni and supporters with a flexible, modern way to give back Foundation Source, the leading provider of philanthropic solutions for donors, nonprofits, institutions, and the wealth advisors who serve them, today announced a partnership withTemple Universityto launch the university's own fully branded donor-advised fund (DAF) program. Powered by Foundation Source's Turnkey DAF

MOMENTUM 2025 kicks off in Riyadh on 9 December

Saudi Arabia's capital, Riyadh, will host the inaugural Development Finance Conference “MOMENTUM” from 9 to 11 December 2025 at the King Abdulaziz International Conference Center. The event is organized by the National Development Fund (NDF) under the theme “Where Development Finance Meets Action.” H.E. Mohammed Al-Tuwaijri, Vice Chairman of the Board of Directors of the

PrecisionLife and Ovation Partner to Develop Precision Medicine Test to Inform Reimbursement of GLP-1 Anti-Obesity Drugs

Collaboration to support value-based reimbursement models for GLP-1 receptor agonists, optimizing patient outcomes, increasing markets, and healthcare sustainability. Ovation.io, a leading human omics and clinical data company, and PrecisionLife, a precision medicine company transforming how complex chronic diseases are understood and managed, today announced a collaboration to develop drug-response biomarkers for glucagon-like peptide-1 receptor agonist

Sendbird Achieves the AWS Generative AI Competency

Sendbird Inc., the AI customer experience company powering conversations for over 300 million people every month, announced today that it has achieved the Amazon Web Services (AWS) Generative AI Competency. This specialization recognizes Sendbird as an AWS Partner that helps customers adopt and implement AWS services, tools, and infrastructure for generative AI. https://mma.prnewswire.com/media/2435182/Sendbird_RGB_Logo.jpg Achieving the

Wolverine Peptide Stack Inquiry Surges Ahead of 2026

Jupiter, Florida, Nov. 25, 2025 (GLOBE NEWSWIRE) — Public interest in the Wolverine peptide stack has accelerated rapidly throughout 2025, becoming one of the most discussed topics in the peptide research ecosystem. In response, WolverinePeptideStack.com has released a newly expanded educational guide designed to clarify terminology, contextualize research discussions, and help readers better understand why

Flare Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference

CAMBRIDGE, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) — Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that Douglas Manion, M.D., FRCP (C), Chief Executive Officer, will present a company overview at the upcoming Piper Sandler 37th Annual Healthcare Conference on

Federal Security Investigation of Foreign Mining Hardware Manufacturer Validates BlockQuarry’s American-Made Strategy

(Other OTC:BLQC),(OTC US:BLQC), HOUSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — BlockQuarry Corp. (OTC: BLQC) (the “Company”), a leading innovator in American-manufactured cryptocurrency mining solutions and sustainable energy infrastructure, today addressed the implications of ongoing federal security investigations into foreign-manufactured mining hardware and how this development reinforces the strategic importance of domestic mining equipment production. Federal

Scroll to Top